Dopamine Receptor d1 Antikörper (AA 11-100)
Kurzübersicht für Dopamine Receptor d1 Antikörper (AA 11-100) (ABIN2173724)
Target
Alle Dopamine Receptor d1 (DRD1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 11-100
-
Kreuzreaktivität
- Human, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Dopamine Receptor D1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
-
Andere Bezeichnung
- Dopamine Receptor D1
-
Hintergrund
-
Synonyms: DADR, DRD1A, D(1A) dopamine receptor, Dopamine D1 receptor, DRD1
Background: Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase.
-
Gen-ID
- 1812
-
UniProt
- P21728
-
Pathways
- cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
Target
-